Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Clinical trial NCT00355407 · COMPLETED

Trial details

NCT number: NCT00355407
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.